The UK government has announced a £25 million boost for hospices across England, marking the first phase of a larger £100 million investment to improve the quality of end-of-life care.
An NHS report of alcohol hospitalisations, alcohol affordability, and prescriptions for drugs to treat alcohol dependence, finds that alcohol misuse is increasing across the UK.
Data reveals that patients with heart disease who come from disadvantaged communities experience more complications after their surgery – including a higher risk of death.
Researchers find that ethnic minority diabetes patients are less likely to take medication for their treatment, due to income differences and lack of access.
A new framework by researchers can help identify and diagnose alcohol use disorder based on symptoms, so patients can be given personalised treatment options.
Parents of babies leaving the NICU have been using an app to get real-time medical updates - giving them vital information that may otherwise get lost.
Research has found that low-intensity transcranial ultrasound stimulation can modulate brain activity and behaviours, supporting the observations of psychiatric conditions.
According to a new study, nearly one in five patients with heart disease use mental health drugs, leading to almost a doubled risk of premature deaths with the condition.
Researching DNA outside of our genes, analysing the ‘dark genome’, scientists have found evolved proteins which can distinguish between schizophrenia and bipolar disorders, improving diagnosis and treatment.
A new minimally invasive and inexpensive blood test can detect a range of cancers in patients with non-specific symptoms, and can indicate whether the cancer has spread.
In a previous article, Lisa Riley, Vice President of Strategic Product and Partnership Development for VitalHub UK, cited how digital healthcare is helping to transform the NHS through whole system integration in planned care, here Stuart Jeffery talks from a customer perspective.
Clint Schick, Chief Executive, Strata Health UK, describes a software system that has made the manual process...digital – freeing up staff time & improving patient care.
Rapidly scaling health-tech player in the emerging Pathology Computer Aided Diagnostics sector Deciphex uses digital pathology and AI to accelerate pathology diagnosis by improving productivity and patient outcome.
Specialists in acute care Draeger Medical UK Ltd prioritise patient wellbeing and efficiency in holistic approach to a well-designed healthcare workplace
Brian Murphy, CSO of UK digital health firm Cumulus Neuroscience, explores how AI tools could transform drug development in the difficult area of cognitive disorders.
